{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T09:08:42Z","timestamp":1779700122295,"version":"3.53.1"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460495"],"award-info":[{"award-number":["82460495"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20242BAB216064"],"award-info":[{"award-number":["20242BAB216064"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20242BAB25353"],"award-info":[{"award-number":["20242BAB25353"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bioorg.2026.109589","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:27:23Z","timestamp":1770222443000},"page":"109589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Protein arginine methyltransferase 3: Mechanism of action in diseases and modulator discovery"],"prefix":"10.1016","volume":"178","author":[{"given":"Dongmin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunjun","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109589_bb0005","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111234118","article-title":"Posttranslational modifications by ADAM10 shape myeloid antigen-presenting cell homeostasis in the splenic marginal zone","volume":"118","author":"Diener","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2026.109589_bb0010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41392-023-01720-0","article-title":"Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2026.109589_bb0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/cac2.12108","article-title":"LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer","volume":"41","author":"Tan","year":"2021","journal-title":"Cancer Commun. (Lond.)"},{"key":"10.1016\/j.bioorg.2026.109589_bb0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/21541264.2017.1291083","article-title":"Regenerating muscle with arginine methylation","volume":"8","author":"Blanc","year":"2017","journal-title":"Transcription"},{"key":"10.1016\/j.bioorg.2026.109589_bb0025","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41573-021-00159-8","article-title":"Protein arginine methylation: from enigmatic functions to therapeutic targeting","volume":"20","author":"Wu","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.109589_bb0030","first-page":"512","article-title":"Arginine: Clinical potential of a semi-essential amino acid","volume":"7","author":"Appleton","year":"2002","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.bioorg.2026.109589_bb0035","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1016\/j.molcel.2021.09.011","article-title":"Cellular pathways influenced by protein arginine methylation: implications for cancer","volume":"81","author":"Xu","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2026.109589_bb0040","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1007\/s00018-019-03140-2","article-title":"Cellular consequences of arginine methylation","volume":"76","author":"Lorton","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bioorg.2026.109589_bb0045","doi-asserted-by":"crossref","first-page":"8854","DOI":"10.3390\/ijms25168854","article-title":"Role of PRMT1 and PRMT5 in breast Cancer","volume":"25","author":"Martinez","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.109589_bb0050","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1021\/acschembio.5b00839","article-title":"A potent, selective, and cell-active inhibitor of human type I protein arginine methyltransferases","volume":"11","author":"Eram","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.109589_bb0055","doi-asserted-by":"crossref","first-page":"18299","DOI":"10.1074\/jbc.M116.740399","article-title":"Protein arginine methyltransferase product specificity is mediated by distinct active-site architectures","volume":"291","author":"Jain","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.109589_bb0060","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41580-019-0155-x","article-title":"The regulation, functions and clinical relevance of arginine methylation","volume":"20","author":"Guccione","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.109589_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177350","article-title":"Targeting protein arginine methyltransferases in breast cancer: promising strategies","volume":"992","author":"Wei","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109589_bb0070","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/s41589-022-01024-4","article-title":"PRMT inhibition induces a viral mimicry response in triple-negative breast cancer","volume":"18","author":"Wu","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.109589_bb0075","doi-asserted-by":"crossref","first-page":"R223","DOI":"10.1530\/JME-18-0224","article-title":"Epigenetic arginine methylation in breast cancer: emerging therapeutic strategies","volume":"62","author":"Wang","year":"2019","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bioorg.2026.109589_bb0080","doi-asserted-by":"crossref","first-page":"18143","DOI":"10.1021\/acs.jmedchem.5c01895","article-title":"PRMT5: a promising Synthetical lethal target for MTAP-deleted cancers","volume":"68","author":"Li","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109589_bb0085","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.annonc.2024.08.2339","article-title":"First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration","volume":"35","author":"Rodon","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bioorg.2026.109589_bb0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1158\/2159-8290.CD-24-0887","article-title":"AMG 193, a clinical stage MTA-cooperative PRMT5 inhibitor, drives antitumor activity preclinically and in patients with MTAP-deleted cancers","volume":"15","author":"Belmontes","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2026.109589_bb0095","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/jnc.13191","article-title":"The protein arginine methyltransferase PRMT5 regulates Abeta-induced toxicity in human cells and Caenorhabditis elegans models of alzheimer's disease","volume":"134","author":"Quan","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bioorg.2026.109589_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70386","article-title":"PRMT3 and CARM1: emerging epigenetic targets in Cancer","volume":"29","author":"Huang","year":"2025","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bioorg.2026.109589_bb0105","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1093\/emboj\/19.14.3509","article-title":"Crystal structure of the conserved core of protein arginine methyltransferase PRMT3","volume":"19","author":"Zhang","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.bioorg.2026.109589_bb0110","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.str.2012.06.001","article-title":"An allosteric inhibitor of protein arginine methyltransferase 3","volume":"20","author":"Siarheyeva","year":"2012","journal-title":"Structure"},{"key":"10.1016\/j.bioorg.2026.109589_bb0115","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1002\/anie.201412154","article-title":"A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3)","volume":"54","author":"Kaniskan","year":"2015","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.bioorg.2026.109589_bb0120","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1021\/acs.jmedchem.7b01674","article-title":"Discovery of potent and selective allosteric inhibitors of protein arginine methyltransferase 3 (PRMT3)","volume":"61","author":"Kaniskan","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109589_bb0125","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1021\/cb4008259","article-title":"Profiling substrates of protein arginine N-methyltransferase 3 with S-adenosyl-L-methionine analogues","volume":"9","author":"Guo","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.109589_bb0130","doi-asserted-by":"crossref","first-page":"16935","DOI":"10.1074\/jbc.273.27.16935","article-title":"PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation","volume":"273","author":"Tang","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.109589_bb0135","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.3390\/molecules200610032","article-title":"Computational study of symmetric methylation on histone arginine catalyzed by protein arginine methyltransferase PRMT5 through QM\/MM MD and free energy simulations","volume":"20","author":"Yue","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109589_bb0140","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1021\/jm3018332","article-title":"Exploiting an allosteric binding site of PRMT3 yields potent and selective inhibitors","volume":"56","author":"Liu","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109589_bb0145","article-title":"PRMT3 drives IDO1-dependent Radioresistance and immunosuppression by promoting kynurenine metabolism in non-small cell lung Cancer","author":"Zhang","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.109589_bb0150","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/s41467-023-37542-5","article-title":"PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer","volume":"14","author":"Shi","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.109589_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145718","article-title":"Arginine methyltransferase PRMT3 promote tumorigenesis through regulating c-MYC stabilization in colorectal cancer","volume":"791","author":"Hu","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.bioorg.2026.109589_bb0160","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1093\/nar\/gky103","article-title":"Arginine methylation of the C-terminus RGG motif promotes TOP3B topoisomerase activity and stress granule localization","volume":"46","author":"Huang","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.109589_bb0165","article-title":"PRMT3-mediated arginine methylation of METTL14 promotes malignant progression and treatment resistance in endometrial carcinoma","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.bioorg.2026.109589_bb0170","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/s41419-021-04352-w","article-title":"PRMT3 promotes tumorigenesis by methylating and stabilizing HIF1alpha in colorectal cancer","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2026.109589_bb0175","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1111\/cas.15724","article-title":"PRMT3 regulates the progression of invasive micropapillary carcinoma of the breast","volume":"114","author":"Zhi","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bioorg.2026.109589_bb0180","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.devcel.2019.04.014","article-title":"YAP\/TAZ inhibition induces metabolic and signaling rewiring resulting in targetable vulnerabilities in NF2-deficient tumor cells","volume":"49","author":"White","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bioorg.2026.109589_bb0185","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s13679-023-00531-2","article-title":"Hypothalamic-ovarian axis and adiposity relationship in polycystic ovary syndrome: physiopathology and therapeutic options for the Management of Metabolic and Inflammatory Aspects","volume":"13","author":"Lonardo","year":"2024","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.bioorg.2026.109589_bb0190","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41419-025-07482-7","article-title":"PRMT3 drives PD-L1-mediated immune escape through activating PDHK1-regulated glycolysis in hepatocellular carcinoma","volume":"16","author":"Ding","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2026.109589_bb0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41590-023-01700-0","article-title":"BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance","volume":"25","author":"Lee","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bioorg.2026.109589_bb0200","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/gutjnl-2015-309897","article-title":"Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response","volume":"66","author":"Blasco-Baque","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.bioorg.2026.109589_bb0205","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2010.07.033","article-title":"PRMT3 is essential for dendritic spine maturation in rat hippocampal neurons","volume":"1352","author":"Miyata","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.bioorg.2026.109589_bb0210","doi-asserted-by":"crossref","first-page":"7930","DOI":"10.1038\/s41467-024-52170-3","article-title":"Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS\/STING signaling","volume":"15","author":"Shi","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.109589_bb0215","doi-asserted-by":"crossref","first-page":"10212","DOI":"10.1096\/fj.201902569R","article-title":"Zebrafish prmt3 negatively regulates antiviral responses","volume":"34","author":"Zhu","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.bioorg.2026.109589_bb0220","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2214956120","article-title":"Asymmetric arginine dimethylation of cytosolic RNA and DNA sensors by PRMT3 attenuates antiviral innate immunity","volume":"120","author":"Zhu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2023","key":"10.1016\/j.bioorg.2026.109589_bb0225","article-title":"NLRP3\/IL-1beta induced myeloid-derived suppressor cells recruitment and PD-L1 upregulation promotes oxaliplatin resistance of hepatocellular carcinoma","volume":"4","author":"Liu","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.bioorg.2026.109589_bb0230","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13046-024-03134-4","article-title":"M(6)A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma","volume":"43","author":"Lin","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.109589_bb0235","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41418-024-01406-2","article-title":"METTL3 confers oxaliplatin resistance through the activation of G6PD-enhanced pentose phosphate pathway in hepatocellular carcinoma","volume":"32","author":"Jin","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioorg.2026.109589_bb0240","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-024-01600-2","article-title":"Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2026.109589_bb0245","first-page":"1045","article-title":"Tumor-associated macrophages restrict CD8(+) T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment","volume":"5","author":"Tharp","year":"2024","journal-title":"Nat. Can."},{"key":"10.1016\/j.bioorg.2026.109589_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115064","article-title":"Metabolic reprogramming, sensing, and cancer therapy","volume":"43","author":"Mao","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioorg.2026.109589_bb0255","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","article-title":"Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2026.109589_bb0260","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13045-024-01527-8","article-title":"Metabolic reprogramming in the tumor microenvironment of liver cancer","volume":"17","author":"Lin","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2026.109589_bb0265","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s10020-023-00759-7","article-title":"PRMT3 methylates HIF-1alpha to enhance the vascular calcification induced by chronic kidney disease","volume":"30","author":"Zhou","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.bioorg.2026.109589_bb0270","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s42003-020-01644-3","article-title":"PRMT3 interacts with ALDH1A1 and regulates gene-expression by inhibiting retinoic acid signaling","volume":"4","author":"Verma","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bioorg.2026.109589_bb0275","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41419-019-1815-7","article-title":"Asymmetrical methyltransferase PRMT3 regulates human mesenchymal stem cell osteogenesis via miR-3648","volume":"10","author":"Min","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2026.109589_bb0280","doi-asserted-by":"crossref","first-page":"177","DOI":"10.31083\/ph.2017.6768","article-title":"mRNA expression profiling of histone modifying enzymes in pediatric acute monoblastic leukemia","volume":"72","author":"Xiao","year":"2017","journal-title":"Pharmazie"},{"key":"10.1016\/j.bioorg.2026.109589_bb0285","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1016\/j.febslet.2013.07.043","article-title":"Protein arginine methyl transferases-3 and -5 increase cell surface expression of cardiac sodium channel","volume":"587","author":"Beltran-Alvarez","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2026.109589_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.07.037","article-title":"Pharmaceutical cocrystals: an overview","volume":"419","author":"Qiao","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2026.109589_bb0295","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1016\/j.apsb.2023.07.022","article-title":"A unique binding pocket induced by a noncanonical SAH mimic to develop potent and selective PRMT inhibitors","volume":"13","author":"Deng","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2026.109589_bb0300","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41416-023-02276-0","article-title":"Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors","volume":"129","author":"El-Khoueiry","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioorg.2026.109589_bb0310","series-title":"Participants with Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL)","article-title":"First time in humans (FTIH) study of GSK3368715","year":"2026"},{"key":"10.1016\/j.bioorg.2026.109589_bb0315","series-title":"Participants with Advanced Solid Tumors, NHL, and Lower Risk MDS","article-title":"A study of JNJ-64619178, an inhibitor of PRMT5","year":"2026"},{"key":"10.1016\/j.bioorg.2026.109589_bb0320","series-title":"Participants with Advanced or Metastatic Solid Tumors","article-title":"A dose escalation study of PF-06939999","year":"2026"},{"key":"10.1016\/j.bioorg.2026.109589_bb0325","series-title":"Early Stage Breast Cancer (OTT-19-06)","article-title":"A Phase II window of opportunity trial of PRMT5 inhibitor, GSK3326595","year":"2026"},{"key":"10.1016\/j.bioorg.2026.109589_bb0330","series-title":"Solid Tumors with MTAP Deletion","article-title":"Phase 1 Study of MRTX1719","year":"2026"},{"key":"10.1016\/j.bioorg.2026.109589_bb0335","series-title":"Patients with MTAP-Deleted Solid Tumors","article-title":"Safety and tolerability of TNG908","year":"2026"},{"key":"10.1016\/j.bioorg.2026.109589_bb0345","series-title":"Dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK3326595 in participants with solid tumors and non-hodgkin's lymphoma (meteor 1)","author":"An Open-label","year":"2026"},{"key":"10.1016\/j.bioorg.2026.109589_bb0355","author":"A Study Evaluating AMG 193 in Combination with other Therapies in Participants with Advanced Gastrointestinal"},{"key":"10.1016\/j.bioorg.2026.109589_bb0365","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1093\/nar\/gkz200","article-title":"PRMT1 loss sensitizes cells to PRMT5 inhibition","volume":"47","author":"Gao","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.109589_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101176","article-title":"PRMT1 inhibitor MS023 suppresses RNA splicing to sensitize small cell lung cancer to DNA damaging agents","volume":"66","author":"Aparnathi","year":"2025","journal-title":"Neoplasia"},{"key":"10.1016\/j.bioorg.2026.109589_bb0375","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13045-019-0769-7","article-title":"Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer","volume":"12","author":"Hsu","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2026.109589_bb0380","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202500729R","article-title":"Interplay of PRMTs and identification of biomarkers through machine learning algorithms in Pan-Cancer, highlighting PRMT3 as a biomarker in pancreatic Cancer","volume":"39","author":"Chen","year":"2025","journal-title":"FASEB J."},{"key":"10.1016\/j.bioorg.2026.109589_bb0385","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/978-981-32-9636-7_23","article-title":"Drug-induced demyelinating neuropathies","volume":"1190","author":"Niimi","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bioorg.2026.109589_bb0390","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.chest.2018.03.056","article-title":"Drug-induced sarcoidosis-like reactions","volume":"154","author":"Chopra","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.bioorg.2026.109589_bb0395","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40264-024-01485-7","article-title":"Drug-induced hypouricemia","volume":"48","author":"Ben Salem","year":"2025","journal-title":"Drug Saf."},{"key":"10.1016\/j.bioorg.2026.109589_bb0400","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.tips.2007.06.008","article-title":"Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act?","volume":"28","author":"Schwartz","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2026.109589_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sbi.2017.10.002","article-title":"Structure-based prediction of protein allostery","volume":"50","author":"Greener","year":"2018","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bioorg.2026.109589_bb0410","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.neuropharm.2017.09.024","article-title":"Allosteric modulators targeting CNS muscarinic receptors","volume":"136","author":"Bock","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bioorg.2026.109589_bb0415","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1021\/acs.jmedchem.5b01772","article-title":"Discovery of a potent class I protein arginine methyltransferase fragment inhibitor","volume":"59","author":"Ferreira de Freitas","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109589_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115713","article-title":"Development of selective class I protein arginine methyltransferase inhibitors through fragment-based drug design approach","volume":"260","author":"Bhattacharya","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109589_bb0425","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3390\/biom11060854","article-title":"A Pan-inhibitor for protein arginine methyltransferase family enzymes","volume":"11","author":"Iyamu","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2026.109589_bb0430","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ccell.2019.05.014","article-title":"Anti-tumor activity of the type I PRMT inhibitor, GSK3368715, synergizes with PRMT5 inhibition through MTAP loss","volume":"36","author":"Fedoriw","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2026.109589_bb0435","article-title":"Discovery of PRMT3 degrader for the treatment of acute leukemia","volume":"11","author":"Zou","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.bioorg.2026.109589_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41401-020-0366-x","article-title":"Small molecule inhibitors targeting the PD-1\/PD-L1 signaling pathway","volume":"42","author":"Wu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioorg.2026.109589_bb0445","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2026.109589_bb0450","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-981-15-3266-5_3","article-title":"Roles of PD-1\/PD-L1 pathway: signaling, Cancer, and beyond","volume":"1248","author":"Ai","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bioorg.2026.109589_bb0455","doi-asserted-by":"crossref","first-page":"8543","DOI":"10.1021\/acs.jmedchem.5c00198","article-title":"Discovery of a potent and selective protein arginine methyltransferase 5 (PRMT5) PROTAC degrader","volume":"68","author":"Zhong","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109589_bb0460","doi-asserted-by":"crossref","first-page":"9977","DOI":"10.1021\/acs.jmedchem.0c01111","article-title":"Discovery of first-in-class protein arginine methyltransferase 5 (PRMT5) degraders","volume":"63","author":"Shen","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109589_bb0465","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175023","article-title":"PRMT5-mediated FUBP1 methylation accelerates prostate cancer progression","volume":"134","author":"Yan","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bioorg.2026.109589_bb0470","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/s41388-023-02674-x","article-title":"PRMT5 methylating SMAD4 activates TGF-beta signaling and promotes colorectal cancer metastasis","volume":"42","author":"Liu","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.109589_bb0475","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1126\/science.aad5214","article-title":"MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells","volume":"351","author":"Kryukov","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2026.109589_bb0480","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1158\/2159-8290.CD-23-0669","article-title":"MRTX1719 is an MTA-cooperative PRMT5 inhibitor that exhibits synthetic lethality in preclinical models and patients with MTAP-deleted Cancer","volume":"13","author":"Engstrom","year":"2023","journal-title":"Cancer Discov."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826001252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826001252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T08:48:05Z","timestamp":1779698885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826001252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":92,"alternative-id":["S0045206826001252"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109589","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein arginine methyltransferase 3: Mechanism of action in diseases and modulator discovery","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109589","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109589"}}